Nitrite reduction and cardiovascular protection

Journal of Molecular and Cellular Cardiology

Volumn 73, Issue , 2014, Pages 57-69

  Omar, Sami A ^a,b   Webb, Andrew James ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cardiovascular protection; Haem globins; Nitrate Nitrite NO pathway; Nitrite; Nitrite reductases; Xanthine oxidoreductase

Indexed keywords

ACETAZOLAMIDE; ALDEHYDE OXIDASE; ALLOPURINOL; C REACTIVE PROTEIN; CARBON DIOXIDE; CARBONATE DEHYDRATASE; CYTOCHROME C; CYTOCHROME C OXIDASE; CYTOCHROME P450; CYTOGLOBIN; DORZOLAMIDE; HEMOGLOBIN; MITOCHONDRIAL ENZYME; MITOCHONDRIAL PROTEIN; MOLYBDENUM METALLOENZYME; MYOGLOBIN; NEUROGLOBIN; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; NITRITE REDUCTASE; NITROGEN DIOXIDE; OXYGEN; PLACEBO; REACTIVE OXYGEN METABOLITE; S NITROSOTHIOL; SULFITE OXIDASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; XANTHINE OXIDASE;

AGING; ANTIHYPERTENSIVE ACTIVITY; ARTERIAL STIFFNESS; BIOAVAILABILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; HEART ARREST; HEART INFARCTION; HEART PROTECTION; HUMAN; HYDROXYLATION; HYPERCHOLESTEROLEMIA; HYPERPLASIA; HYPERTENSION; HYPOXIA; INTIMAL HYPERPLASIA; LIMB ISCHEMIA; NITROSATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXYGEN AFFINITY; OXYGEN TENSION; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PURINE METABOLISM; REDUCTION; REVIEW; SIGNAL TRANSDUCTION; VASODILATATION; ANIMAL; CARDIOVASCULAR SYSTEM; METABOLISM;

ANIMALS; CARDIOVASCULAR SYSTEM; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; OXIDATION-REDUCTION; S-NITROSOTHIOLS;

EID: 84901819805     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.01.012     Document Type: Review

References (227)

1. Kleinbongard P., Dejam A., Lauer T., Rassaf T., Schindler A., Picker O., et al. Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic Biol Med 2003, 35:790-796.
2. Leaf C.D., Wishnok J.S., Tannenbaum S.R. L-Arginine is a precursor for nitrate biosynthesis in humans. Biochem Biophys Res Commun 1989, 163:1032-1037.
3. Rhodes P., Leone A.M., Francis P.L., Struthers A.D., Moncada S., Rhodes P.M. The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem Biophys Res Commun 1995, 209:590-596.
4. Lidder S., Webb A.J. Vascular effects of dietary nitrate (as found in green leafy vegetables and beetroot) via the nitrate-nitrite-nitric oxide pathway. Br J Clin Pharmacol 2013, 75:677-696.
5. Lauer T., Preik M., Rassaf T., Strauer B.E., Deussen A., Feelisch M., et al. Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proc Natl Acad Sci U S A 2001, 98:12814-12819.
6. Govoni M., Jansson E.A., Weitzberg E., Lundberg J.O. The increase in plasma nitrite after a dietary nitrate load is markedly attenuated by an antibacterial mouthwash. Nitric Oxide 2008, 19:333-337.
7. Pannala A.S., Mani A.R., Spencer J.P., Skinner V., Bruckdorfer K.R., Moore K.P., et al. The effect of dietary nitrate on salivary, plasma, and urinary nitrate metabolism in humans. Free Radic Biol Med 2003, 34:576-584.
8. Kleinbongard P., Dejam A., Lauer T., Jax T., Kerber S., Gharini P., et al. Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans. Free Radic Biol Med 2006, 40:295-302.
9. Bryan N.S., Rassaf T., Maloney R.E., Rodriguez C.M., Saijo F., Rodriguez J.R., et al. Cellular targets and mechanisms of nitros(yl)ation: an insight into their nature and kinetics in vivo. Proc Natl Acad Sci U S A 2004, 101:4308-4313.
10. Gorenflo M., Zheng C., Poge A., Bettendorf M., Werle E., Fiehn W., et al. Metabolites of the L-arginine-NO pathway in patients with left-to-right shunt. Clin Lab 2001, 47:441-447.
11. Bryan N.S., Fernandez B.O., Bauer S.M., Garcia-Saura M.F., Milsom A.B., Rassaf T., et al. Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues. Nat Chem Biol 2005, 1:290-297.
12. Totzeck M., Hendgen-Cotta U.B., Luedike P., Berenbrink M., Klare J.P., Steinhoff H.J., et al. Nitrite regulates hypoxic vasodilation via myoglobin-dependent nitric oxide generation. Circulation 2012, 126:325-334.
13. Butler A.R., Feelisch M. Therapeutic uses of inorganic nitrite and nitrate: from the past to the future. Circulation 2008, 117:2151-2159.
14. Gilchrist M., Winyard P.G., Benjamin N. Dietary nitrate - good or bad?. Nitric Oxide 2010, 22:104-109.
15. Omar S.A., Artime E., Webb A.J. A comparison of organic and inorganic nitrates/nitrites. Nitric Oxide 2012, 26:229-240.
16. Wagner D.A., Schultz D.S., Deen W.M., Young V.R., Tannenbaum S.R. Metabolic fate of an oral dose of 15 N-labeled nitrate in humans: effect of diet supplementation with ascorbic acid. Cancer Res 1983, 43:1921-1925.
17. Florin T.H., Neale G., Cummings J.H. The effect of dietary nitrate on nitrate and nitrite excretion in man. Br J Nutr 1990, 64:387-397.
18. Doel J.J., Benjamin N., Hector M.P., Rogers M., Allaker R.P. Evaluation of bacterial nitrate reduction in the human oral cavity. Eur J Oral Sci 2005, 113:14-19.
19. Lundberg J.O., Weitzberg E., Lundberg J.M., Alving K. Intragastric nitric oxide production in humans: measurements in expelled air. Gut 1994, 35:1543-1546.
20. Benjamin N., O'Driscoll F., Dougall H., Duncan C., Smith L., Golden M., et al. Stomach NO synthesis. Nature 1994, 368:502.
21. Jansson E.A., Huang L., Malkey R., Govoni M., Nihlen C., Olsson A., et al. A mammalian functional nitrate reductase that regulates nitrite and nitric oxide homeostasis. Nat Chem Biol 2008, 4:411-417.
22. Furchgott R.F., Bhadrakom S. Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs. J Pharmacol Exp Ther 1953, 108:129-143.
23. Zweier J.L., Wang P., Samouilov A., Kuppusamy P. Enzyme-independent formation of nitric oxide in biological tissues. Nat Med 1995, 1:804-809.
24. Cicinelli E., Ignarro L.J., Schonauer L.M., Matteo M.G., Galantino P., Falco N. Different plasma levels of nitric oxide in arterial and venous blood. Clin Physiol 1999, 19:440-442.
25. Gladwin M.T., Shelhamer J.H., Schechter A.N., Pease-Fye M.E., Waclawiw M.A., Panza J.A., et al. Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. Proc Natl Acad Sci U S A 2000, 97:11482-11487.
26. Luchsinger B.P., Rich E.N., Yan Y., Williams E.M., Stamler J.S., Singel D.J. Assessments of the chemistry and vasodilatory activity of nitrite with hemoglobin under physiologically relevant conditions. J Inorg Biochem 2005, 99:912-921.
27. Modin A., Bjorne H., Herulf M., Alving K., Weitzberg E., Lundberg J.O. Nitrite-derived nitric oxide: a possible mediator of 'acidic-metabolic' vasodilation. Acta Physiol Scand 2001, 171:9-16.
28. Cosby K., Partovi K.S., Crawford J.H., Patel R.P., Reiter C.D., Martyr S., et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 2003, 9:1498-1505.
29. Maher A.R., Milsom A.B., Gunaruwan P., Abozguia K., Ahmed I., Weaver R.A., et al. Hypoxic modulation of exogenous nitrite-induced vasodilation in humans. Circulation 2008, 117:670-677.
30. Ursell P.C., Mayes M. The majority of nitric oxide synthase in pig heart is vascular and not neural. Cardiovasc Res 1993, 27:1920-1924.
31. Balligand J.L., Kobzik L., Han X., Kaye D.M., Belhassen L., O'Hara D.S., et al. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem 1995, 270:14582-14586.
32. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol 2001, 33:1897-1918.
33. Li H., Cui H., Kundu T.K., Alzawahra W., Zweier J.L. Nitric oxide production from nitrite occurs primarily in tissues not in the blood: critical role of xanthine oxidase and aldehyde oxidase. J Biol Chem 2008, 283:17855-17863.
34. Giraldez R.R., Panda A., Xia Y., Sanders S.P., Zweier J.L. Decreased nitric-oxide synthase activity causes impaired endothelium-dependent relaxation in the postischemic heart. J Biol Chem 1997, 272:21420-21426.
35. Samouilov A., Kuppusamy P., Zweier J.L. Evaluation of the magnitude and rate of nitric oxide production from nitrite in biological systems. Arch Biochem Biophys 1998, 357:1-7.
36. Lundberg J.O., Weitzberg E. NO generation from nitrite and its role in vascular control. Arterioscler Thromb Vasc Biol 2005, 25:915-922.
37. Hardison R.C. A brief history of hemoglobins: plant, animal, protist, and bacteria. Proc Natl Acad Sci U S A 1996, 93:5675-5679.
38. Rayner B.S., Hua S., Sabaretnam T., Witting P.K. Nitric oxide stimulates myoglobin gene and protein expression in vascular smooth muscle. Biochem J 2009, 423:169-177.
39. Cossins A.R., Williams D.R., Foulkes N.S., Berenbrink M., Kipar A. Diverse cell-specific expression of myoglobin isoforms in brain, kidney, gill and liver of the hypoxia-tolerant carp and zebrafish. J Exp Biol 2009, 212:627-638.
40. Shiva S., Huang Z., Grubina R., Sun J., Ringwood L.A., MacArthur P.H., et al. Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ Res 2007, 100:654-661.
41. Burmester T., Weich B., Reinhardt S., Hankeln T. A vertebrate globin expressed in the brain. Nature 2000, 407:520-523.
42. Reeder B.J. The redox activity of hemoglobins: from physiologic functions to pathologic mechanisms. Antioxid Redox Signal 2010, 13:1087-1123.
43. Fordel E., Thijs L., Moens L., Dewilde S. Neuroglobin and cytoglobin expression in mice. Evidence for a correlation with reactive oxygen species scavenging. FEBS J 2007, 274:1312-1317.
44. Tiso M., Tejero J., Basu S., Azarov I., Wang X., Simplaceanu V., et al. Human neuroglobin functions as a redox-regulated nitrite reductase. J Biol Chem 2011, 286:18277-18289.
45. Fordel E., Geuens E., Dewilde S., Rottiers P., Carmeliet P., Grooten J., et al. Cytoglobin expression is upregulated in all tissues upon hypoxia: an in vitro and in vivo study by quantitative real-time PCR. Biochem Biophys Res Commun 2004, 319:342-348.
46. Burmester T., Ebner B., Weich B., Hankeln T. Cytoglobin: a novel globin type ubiquitously expressed in vertebrate tissues. Mol Biol Evol 2002, 19:416-421.
47. Kozlov A.V., Staniek K., Nohl H. Nitrite reductase activity is a novel function of mammalian mitochondria. FEBS Lett 1999, 454:127-130.
48. Basu S., Azarova N.A., Font M.D., King S.B., Hogg N., Gladwin M.T., et al. Nitrite reductase activity of cytochrome c. J Biol Chem 2008, 283:32590-32597.
49. Ferguson-Miller S., Hiser C., Liu J. Gating and regulation of the cytochrome c oxidase proton pump. Biochim Biophys Acta 1817, 2012:489-494.
50. Castello P.R., David P.S., McClure T., Crook Z., Poyton R.O. Mitochondrial cytochrome oxidase produces nitric oxide under hypoxic conditions: implications for oxygen sensing and hypoxic signaling in eukaryotes. Cell Metab 2006, 3:277-287.
51. Godber B.L., Doel J.J., Sapkota G.P., Blake D.R., Stevens C.R., Eisenthal R., et al. Reduction of nitrite to nitric oxide catalyzed by xanthine oxidoreductase. J Biol Chem 2000, 275:7757-7763.
52. Harrison R. Structure and function of xanthine oxidoreductase: where are we now?. Free Radic Biol Med 2002, 33:774-797.
53. Nishino T., Okamoto K., Eger B.T., Pai E.F. Mammalian xanthine oxidoreductase - mechanism of transition from xanthine dehydrogenase to xanthine oxidase. FEBS J 2008, 275:3278-3289.
54. Garattini E., Fratelli M., Terao M. Mammalian aldehyde oxidases: genetics, evolution and biochemistry. Cell Mol Life Sci 2008, 65:1019-1048.
55. Kundu T.K., Velayutham M., Zweier J.L. Aldehyde oxidase functions as a superoxide generating NADH oxidase: an important redox regulated pathway of cellular oxygen radical formation. Biochemistry 2012, 51:2930-2939.
56. Wang J., Fischer K., Zhao X.J., Tejero J., Kelley E.E., Wang L., et al. Novel function of sulfite oxidase as a nitrite reductase that generates nitric oxide. Free Radic Biol Med 2010, 49:816-821.
57. Woo W.H., Yang H., Wong K.P., Halliwell B. Sulphite oxidase gene expression in human brain and in other human and rat tissues. Biochem Biophys Res Commun 2003, 305:619-623.
58. Nelson D.R. Progress in tracing the evolutionary paths of cytochrome P450. Biochim Biophys Acta 1814, 2011:14-18.
59. Hendrychova T., Anzenbacherova E., Hudecek J., Skopalik J., Lange R., Hildebrandt P., et al. Flexibility of human cytochrome P450 enzymes: molecular dynamics and spectroscopy reveal important function-related variations. Biochim Biophys Acta 1814, 2011:58-68.
60. Immoos C.E., Chou J., Bayachou M., Blair E., Greaves J., Farmer P.J. Electrocatalytic reductions of nitrite, nitric oxide, and nitrous oxide by thermophilic cytochrome P450 CYP119 in film-modified electrodes and an analytical comparison of its catalytic activities with myoglobin. J Am Chem Soc 2004, 126:4934-4942.
61. Feelisch M., Fernandez B.O., Bryan N.S., Garcia-Saura M.F., Bauer S., Whitlock D.R., et al. Tissue processing of nitrite in hypoxia: an intricate interplay of nitric oxide-generating and -scavenging systems. J Biol Chem 2008, 283:33927-33934.
62. Pastorekova S., Parkkila S., Pastorek J., Supuran C.T. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J Enzyme Inhib Med Chem 2004, 19:199-229.
63. Aamand R., Dalsgaard T., Jensen F.B., Simonsen U., Roepstorff A., Fago A. Generation of nitric oxide from nitrite by carbonic anhydrase: a possible link between metabolic activity and vasodilation. Am J Physiol-Heart C 2009, 297:H2068-H2074.
64. Villanueva C., Giulivi C. Subcellular and cellular locations of nitric oxide synthase isoforms as determinants of health and disease. Free Radic Biol Med 2010, 49:307-316.
65. Gautier C., van Faassen E., Mikula I., Martasek P., Slama-Schwok A. Endothelial nitric oxide synthase reduces nitrite anions to NO under anoxia. Biochem Biophys Res Commun 2006, 341:816-821.
66. Bocahut A., Bernad S., Sebban P., Sacquin-Mora S. Relating the diffusion of small ligands in human neuroglobin to its structural and mechanical properties. J Phys Chem B 2009, 113:16257-16267.
67. Taboy C.H., Faulkner K.M., Kraiter D., Bonaventura C., Crumbliss A.L. Concentration-dependent effects of anions on the anaerobic oxidation of hemoglobin and myoglobin. J Biol Chem 2000, 275:39048-39054.
68. Gladwin M.T., Kim-Shapiro D.B. The functional nitrite reductase activity of the heme-globins. Blood 2008, 112:2636-2647.
69. Liao J.C., Hein T.W., Vaughn M.W., Huang K.T., Kuo L. Intravascular flow decreases erythrocyte consumption of nitric oxide. Proc Natl Acad Sci U S A 1999, 96:8757-8761.
70. Dejam A., Hunter C.J., Pelletier M.M., Hsu L.L., Machado R.F., Shiva S., et al. Erythrocytes are the major intravascular storage sites of nitrite in human blood. Blood 2005, 106:734-739.
71. Fraser T.R., Rutherford W., Gamgee A. Report on the progress of physiology: from 1st August 1867, to 1st March 1868. J Anat Physiol 1868, 2:407-431.
72. Haldane J. The red colour of salted meat. J Hyg (Lond) 1901, 1:115-122.
73. Doyle M.P., Pickering R.A., DeWeert T.M., Hoekstra J.W., Pater D. Kinetics and mechanism of the oxidation of human deoxyhemoglobin by nitrites. J Biol Chem 1981, 256:12393-12398.
74. Reutov V.P., Sorokina E.G., Pinelis V.G., Korshunova T.S., Rodionov A.A., Koshelev V.B., et al. The compensatory-adaptive mechanisms in nitrite-induced hypoxia in rats. Biull Eksp Biol Med 1993, 116:506-508.
75. Gladwin M.T., Huang Z., Shiva S., Kim-Shapiro D.B., Patel R.P., Ringwood L.A., et al. Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control. J Clin Invest 2005, 115:2099-2107.
76. Crawford J.H., Isbell T.S., Huang Z., Shiva S., Chacko B.K., Schechter A.N., et al. Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation. Blood 2006, 107:566-574.
77. Huang K.T., Keszler A., Patel N., Patel R.P., Gladwin M.T., Kim-Shapiro D.B., et al. The reaction between nitrite and deoxyhemoglobin. Reassessment of reaction kinetics and stoichiometry. J Biol Chem 2005, 280:31126-31131.
78. Hub J.S., Kubitzki M.B., de Groot B.L. Spontaneous quaternary and tertiary T-R transitions of human hemoglobin in molecular dynamics simulation. PLoS Comput Biol 2010, 6:e1000774.
79. Nagababu E., Ramasamy S., Abernethy D.R., Rifkind J.M. Active nitric oxide produced in the red cell under hypoxic conditions by deoxyhemoglobin-mediated nitrite reduction. J Biol Chem 2003, 278:46349-46356.
80. Eich R.F., Li T., Lemon D.D., Doherty D.H., Curry S.R., Aitken J.F., et al. Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochemistry 1996, 35:6976-6983.
81. Rusak T., Misztal T., Piszcz J., Tomasiak M. Nitric oxide scavenging by cell free hemoglobin may be a primary factor determining hypertension in polycythemic patients. Free Radic Res 2013, 48(2):230-238.
82. Doyle M.P., Hoekstra J.W. Oxidation of nitrogen oxides by bound dioxygen in hemoproteins. J Inorg Biochem 1981, 14:351-358.
83. Jia L., Bonaventura C., Bonaventura J., Stamler J.S. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996, 380:221-226.
84. Gladwin M.T., Ognibene F.P., Pannell L.K., Nichols J.S., Pease-Fye M.E., Shelhamer J.H., et al. Relative role of heme nitrosylation and beta-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation. Proc Natl Acad Sci U S A 2000, 97:9943-9948.
85. Rassaf T., Bryan N.S., Maloney R.E., Specian V., Kelm M., Kalyanaraman B., et al. NO adducts in mammalian red blood cells: too much or too little?. Nat Med 2003, 9:481-482. [author reply 2-3].
86. Basu S., Grubina R., Huang J., Conradie J., Huang Z., Jeffers A., et al. Catalytic generation of N2O3 by the concerted nitrite reductase and anhydrase activity of hemoglobin. Nat Chem Biol 2007, 3:785-794.
87. Hopmann K.H., Cardey B., Gladwin M.T., Kim-Shapiro D.B., Ghosh A. Hemoglobin as a nitrite anhydrase: modeling methemoglobin-mediated N2O3 formation. Chemistry 2011, 17:6348-6358.
88. Rassaf T., Flogel U., Drexhage C., Hendgen-Cotta U., Kelm M., Schrader J. Nitrite reductase function of deoxymyoglobin: oxygen sensor and regulator of cardiac energetics and function. Circ Res 2007, 100:1749-1754.
89. Gros G., Wittenberg B.A., Jue T. Myoglobin's old and new clothes: from molecular structure to function in living cells. J Exp Biol 2010, 213:2713-2725.
90. Garry D.J., Ordway G.A., Lorenz J.N., Radford N.B., Chin E.R., Grange R.W., et al. Mice without myoglobin. Nature 1998, 395:905-908.
91. Cossins A., Berenbrink M. Physiology: myoglobin's new clothes. Nature 2008, 454:416-417.
92. Reutov V.P., Sorokina E.G. NO-synthase and nitrite-reductase components of nitric oxide cycle. Biochemistry (Mosc) 1998, 63:874-884.
93. Ormerod J.O.M., Ashrafian H., Maher A.R., Arif S., Steeples V., Born G.V.R., et al. The role of vascular myoglobin in nitrite-mediated blood vessel relaxation. Cardiovasc Res 2011, 89:560-565.
94. Flogel U., Merx M.W., Godecke A., Decking U.K., Schrader J. Myoglobin: a scavenger of bioactive NO. Proc Natl Acad Sci U S A 2001, 98:735-740.
95. Pesce A., Bolognesi M., Bocedi A., Ascenzi P., Dewilde S., Moens L., et al. Neuroglobin and cytoglobin. Fresh blood for the vertebrate globin family. EMBO Rep 2002, 3:1146-1151.
96. Schmidt M., Gerlach F., Avivi A., Laufs T., Wystub S., Simpson J.C., et al. Cytoglobin is a respiratory protein in connective tissue and neurons, which is up-regulated by hypoxia. J Biol Chem 2004, 279:8063-8069.
97. Li H., Hemann C., Abdelghany T.M., El-Mahdy M.A., Zweier J.L. Characterization of the mechanism and magnitude of cytoglobin-mediated nitrite reduction and nitric oxide generation under anaerobic conditions. J Biol Chem 2012, 287:36623-36633.
98. Nicolis S., Monzani E., Ciaccio C., Ascenzi P., Moens L., Casella L. Reactivity and endogenous modification by nitrite and hydrogen peroxide: does human neuroglobin act only as a scavenger?. Biochem J 2007, 407:89-99.
99. Piknova B., Schechter A.N. Comments on 'vascular effects of dietary nitrate (as found in green leafy vegetables and beetroot) via the nitrate-nitrite-nitric oxide pathway'. Br J Clin Pharmacol 2013, 75:1541-1542.
100. Webb A.J., Lidder S. Reply to comments on 'vascular effects of dietary nitrate (as found in green leafy vegetables and beetroot) via the nitrate-nitrite-nitric oxide pathway'. Br J Clin Pharmacol 2013, 75:1543-1544.
101. Shiva S. Nitrite: a physiological store of nitric oxide and modulator of mitochondrial function. Redox Biol 2013, 1:40-44.
102. Walters C.L., Taylor A.M. The reduction of nitrite by skeletal-muscle mitochondria. Biochim Biophys Acta 1965, 96:522-524.
103. Nohl H., Staniek K., Sobhian B., Bahrami S., Redl H., Kozlov A.V. Mitochondria recycle nitrite back to the bioregulator nitric monoxide. Acta Biochim Pol 2000, 47:913-921.
104. Castello P.R., Woo D.K., Ball K., Wojcik J., Liu L., Poyton R.O. Oxygen-regulated isoforms of cytochrome c oxidase have differential effects on its nitric oxide production and on hypoxic signaling. Proc Natl Acad Sci U S A 2008, 105:8203-8208.
105. Schwarz G., Mendel R.R., Ribbe M.W. Molybdenum cofactors, enzymes and pathways. Nature 2009, 460:839-847.
106. Zhang Z., Naughton D., Winyard P.G., Benjamin N., Blake D.R., Symons M.C. Generation of nitric oxide by a nitrite reductase activity of xanthine oxidase: a potential pathway for nitric oxide formation in the absence of nitric oxide synthase activity. Biochem Biophys Res Commun 1998, 249:767-772.
107. Kooij A., Schiller H.J., Schijns M., Van Noorden C.J., Frederiks W.M. Conversion of xanthine dehydrogenase into xanthine oxidase in rat liver and plasma at the onset of reperfusion after ischemia. Hepatology 1994, 19:1488-1495.
108. Vickers S., Schiller H.J., Hildreth J.E., Bulkley G.B. Immunoaffinity localization of the enzyme xanthine oxidase on the outside surface of the endothelial cell plasma membrane. Surgery 1998, 124:551-560.
109. Kelley E.E., Hock T., Khoo N.K., Richardson G.R., Johnson K.K., Powell P.C., et al. Moderate hypoxia induces xanthine oxidoreductase activity in arterial endothelial cells. Free Radic Biol Med 2006, 40:952-959.
110. Cantu-Medellin N., Kelley E.E. Xanthine oxidoreductase-catalyzed reduction of nitrite to nitric oxide: insights regarding where, when and how. Nitric Oxide 2013, 34:19-26.
111. Maia L.B., Moura J.J. Nitrite reduction by xanthine oxidase family enzymes: a new class of nitrite reductases. J Biol Inorg Chem 2011, 16:443-460.
112. Webb A., Bond R., McLean P., Uppal R., Benjamin N., Ahluwalia A. Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. Proc Natl Acad Sci U S A 2004, 101:13683-13688.
113. Li H., Samouilov A., Liu X., Zweier J.L. Characterization of the effects of oxygen on xanthine oxidase-mediated nitric oxide formation. J Biol Chem 2004, 279:16939-16946.
114. Webb A.J., Ahluwalia A., Ignarro L.J. Mechanisms of nitrite reduction in ischemia in the cardiovascular system. Nitric Oxide: Biology and pathobiology 2010, Elsevier, USA. L.J. Ignarro (Ed.).
115. Webb A.J., Milsom A.B., Rathod K.S., Chu W.L., Qureshi S., Lovell M.J., et al. Mechanisms underlying erythrocyte and endothelial nitrite reduction to nitric oxide in hypoxia: role for xanthine oxidoreductase and endothelial nitric oxide synthase. Circ Res 2008, 103:957-964.
116. Ghosh S.M., Kapil V., Fuentes-Calvo I., Bubb K.J., Pearl V., Milsom A.B., et al. Enhanced vasodilator activity of nitrite in hypertension: critical role for erythrocytic xanthine oxidoreductase and translational potential. Hypertension 2013, 61:1091-1102.
117. Saito T., Nishino T. Differences in redox and kinetic properties between NAD-dependent and O2-dependent types of rat liver xanthine dehydrogenase. J Biol Chem 1989, 264:10015-10022.
118. Enroth C., Eger B.T., Okamoto K., Nishino T., Pai E.F. Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: structure-based mechanism of conversion. Proc Natl Acad Sci U S A 2000, 97:10723-10728.
119. Sanders S.A., Eisenthal R., Harrison R. NADH oxidase activity of human xanthine oxidoreductase - generation of superoxide anion. Eur J Biochem 1997, 245:541-548.
120. Rocha S., Ferreira A.C., Dias A.I., Vieira J.P., Sequeira S. Sulfite oxidase deficiency - an unusual late and mild presentation. Brain Dev 2013, 36(2):176-179.
121. Klein E.L., Astashkin A.V., Raitsimring A.M., Enemark J.H. Applications of pulsed EPR spectroscopy to structural studies of sulfite oxidizing enzymes. Coord Chem Rev 2013, 257:110-118.
122. Gilmour K.M. Perspectives on carbonic anhydrase. Comp Biochem Physiol A Mol Integr Physiol 2010, 157:193-197.
123. Supuran C.T. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008, 7:168-181.
124. Chegwidden W.R., Dodgson S.J., Spencer I.M. The roles of carbonic anhydrase in metabolism, cell growth and cancer in animals. EXS 2000, 343-363.
125. Aamand R., Ho Y.C., Dalsgaard T., Roepstorff A., Lund T.E. Dietary nitrate facilitates an acetazolamide-induced increase in cerebral blood flow during visual stimulation. J Appl Physiol 2013, 116(3):267-273.
126. Cozier G.E., Leese M.P., Lloyd M.D., Baker M.D., Thiyagarajan N., Acharya K.R., et al. Structures of human carbonic anhydrase II/inhibitor complexes reveal a second binding site for steroidal and nonsteroidal inhibitors. Biochemistry 2010, 49:3464-3476.
127. Supuran C.T. Carbonic anhydrases - an overview. Curr Pharm Des 2008, 14:603-614.
128. Jensen F.B. Red blood cell pH, the Bohr effect, and other oxygenation-linked phenomena in blood O2 and CO2 transport. Acta Physiol Scand 2004, 182:215-227.
129. Innocenti A., Zimmerman S., Ferry J.G., Scozzafava A., Supuran C.T. Carbonic anhydrase inhibitors. Inhibition of the beta-class enzyme from the methanoarchaeon Methanobacterium thermoautotrophicum (Cab) with anions. Bioorg Med Chem Lett 2004, 14:4563-4567.
130. Cardenas AJP A.R., Warren T. Conversion of nitrite to nitric oxide at zinc via S-nitrosothiols. R Soc Chem 2013, 50(2):168-170.
131. Moncada S. Nitric oxide: discovery and impact on clinical medicine. J R Soc Med 1999, 92:164-169.
132. Vanin A.F., Bevers L.M., Slama-Schwok A., van Faassen E.E. Nitric oxide synthase reduces nitrite to NO under anoxia. Cell Mol Life Sci 2007, 64:96-103.
133. Gricman L., Vogel C., Pleiss J. Conservation analysis of class-specific positions in cytochrome P450 monooxygenases: functional and structural relevance. Proteins 2013, (electronic publication ahead of printing).
134. Curtis E., Hsu L.L., Noguchi A.C., Geary L., Shiva S. Oxygen regulates tissue nitrite metabolism. Antioxid Redox Signal 2012, 17:951-961.
135. Ignarro L.J. Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. J Physiol Pharmacol 2002, 53:503-514.
136. Napoli C., Ignarro L.J. Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch Pharm Res 2009, 32:1103-1108.
137. Duranski M.R., Greer J.J., Dejam A., Jaganmohan S., Hogg N., Langston W., et al. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest 2005, 115:1232-1240.
138. Kumar D., Branch B.G., Pattillo C.B., Hood J., Thoma S., Simpson S., et al. Chronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesis. Proc Natl Acad Sci U S A 2008, 105:7540-7545.
139. Gonzalez F.M., Shiva S., Vincent P.S., Ringwood L.A., Hsu L.Y., Hon Y.Y., et al. Nitrite anion provides potent cytoprotective and antiapoptotic effects as adjunctive therapy to reperfusion for acute myocardial infarction. Circulation 2008, 117:2986-2994.
140. Dezfulian C., Shiva S., Alekseyenko A., Pendyal A., Beiser D.G., Munasinghe J.P., et al. Nitrite therapy after cardiac arrest reduces reactive oxygen species generation, improves cardiac and neurological function, and enhances survival via reversible inhibition of mitochondrial complex I. Circulation 2009, 120:897-905.
141. Sindler A.L., Fleenor B.S., Calvert J.W., Marshall K.D., Zigler M.L., Lefer D.J., et al. Nitrite supplementation reverses vascular endothelial dysfunction and large elastic artery stiffness with aging. Aging Cell 2011, 10:429-437.
142. Alef M.J., Vallabhaneni R., Carchman E., Morris S.M., Shiva S., Wang Y., et al. Nitrite-generated NO circumvents dysregulated arginine/NOS signaling to protect against intimal hyperplasia in Sprague-Dawley rats. J Clin Invest 2011, 121:1646-1656.
143. Pride C.K., Mo L., Quesnelle K., Dagda R.K., Murillo D., Geary L., et al. Nitrite activates protein kinase A in normoxia to mediate mitochondrial fusion and tolerance to ischemia/reperfusion. Cardiovasc Res 2013, 101(1):57-68.
144. Bir S.C., Pattillo C.B., Pardue S., Kolluru G.K., Docherty J., Goyette D., et al. Nitrite anion stimulates ischemic arteriogenesis involving NO metabolism. Am J Physiol Heart Circ Physiol 2012, 303:H178-H188.
145. Amin A., Choi S.K., Osman-Elazeik Y., Badr El-Din N.K., Kevil C.G., Navar L.G., et al. Sodium nitrite therapy rescues ischemia-induced neovascularization and blood flow recovery in hypertension. Pflugers Arch 2012, 464:583-592.
146. Bir S.C., Pattillo C.B., Pardue S., Kolluru G.K., Shen X., Giordano T., et al. Nitrite anion therapy protects against chronic ischemic tissue injury in Db/Db diabetic mice in a NO/VEGF dependent manner. Diabetes 2013, 63(1):270-281.
147. Bryan N.S., Calvert J.W., Elrod J.W., Gundewar S., Ji S.Y., Lefer D.J. Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injury. Proc Natl Acad Sci U S A 2007, 104:19144-19149.
148. Shiva S., Sack M.N., Greer J.J., Duranski M., Ringwood L.A., Burwell L., et al. Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med 2007, 204:2089-2102.
149. Hendgen-Cotta U.B., Merx M.W., Shiva S., Schmitz J., Becher S., Klare J.P., et al. Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia-reperfusion injury. Proc Natl Acad Sci U S A 2008, 105:10256-10261.
150. Baker J.E., Su J., Fu X., Hsu A., Gross G.J., Tweddell J.S., et al. Nitrite confers protection against myocardial infarction: role of xanthine oxidoreductase, NADPH oxidase and K(ATP) channels. J Mol Cell Cardiol 2007, 43:437-444.
151. Ingram T.E., Fraser A.G., Bleasdale R.A., Ellins E.A., Margulescu A.D., Halcox J.P., et al. Low-dose sodium nitrite attenuates myocardial ischemia and vascular ischemia-reperfusion injury in human models. J Am Coll Cardiol 2013, 61:2534-2541.
152. Webb A.J., Patel N., Loukogeorgakis S., Okorie M., Aboud Z., Misra S., et al. Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension 2008, 51:784-790.
153. Kannel W.B., McGee D., Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol 1976, 38:46-51.
154. Lakatta E.G., Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation 2003, 107:139-146.
155. Stokes K.Y., Cooper D., Tailor A., Granger D.N. Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. Free Radic Biol Med 2002, 33:1026-1036.
156. Stapleton P.A., Goodwill A.G., James M.E., Brock R.W., Frisbee J.C. Hypercholesterolemia and microvascular dysfunction: interventional strategies. J Inflamm (Lond) 2010, 7:54.
157. Stokes K.Y., Dugas T.R., Tang Y., Garg H., Guidry E., Bryan N.S. Dietary nitrite prevents hypercholesterolemic microvascular inflammation and reverses endothelial dysfunction. Am J Physiol Heart Circ Physiol 2009, 296:H1281-H1288.
158. Classen H.G., Stein-Hammer C., Thoni H. Hypothesis: the effect of oral nitrite on blood pressure in the spontaneously hypertensive rat. Does dietary nitrate mitigate hypertension after conversion to nitrite?. J Am Coll Nutr 1990, 9:500-502.
159. Vleeming W., van de Kuil A., te Biesebeek J.D., Meulenbelt J., Boink A.B. Effect of nitrite on blood pressure in anaesthetized and free-moving rats. Food Chem Toxicol 1997, 35:615-619.
160. Montenegro M.F., Amaral J.H., Pinheiro L.C., Sakamoto E.K., Ferreira G.C., Reis R.I., et al. Sodium nitrite downregulates vascular NADPH oxidase and exerts antihypertensive effects in hypertension. Free Radic Biol Med 2011, 51:144-152.
161. Larsen F.J., Ekblom B., Sahlin K., Lundberg J.O., Weitzberg E. Effects of dietary nitrate on blood pressure in healthy volunteers. N Engl J Med 2006, 355:2792-2793.
162. Sobko T., Marcus C., Govoni M., Kamiya S. Dietary nitrate in Japanese traditional foods lowers diastolic blood pressure in healthy volunteers. Nitric Oxide 2010, 22:136-140.
163. Vanhatalo A., Bailey S.J., Blackwell J.R., DiMenna F.J., Pavey T.G., Wilkerson D.P., et al. Acute and chronic effects of dietary nitrate supplementation on blood pressure and the physiological responses to moderate-intensity and incremental exercise. Am J Physiol Regul Integr Comp Physiol 2010, 299:R1121-R1131.
164. Kapil V., Milsom A.B., Okorie M., Maleki-Toyserkani S., Akram F., Rehman F., et al. Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived NO. Hypertension 2010, 56:274-281.
165. Hobbs D.A., Kaffa N., George T.W., Methven L., Lovegrove J.A. Blood pressure-lowering effects of beetroot juice and novel beetroot-enriched bread products in normotensive male subjects. Br J Nutr 2012, 108:2066-2074.
166. Coles L.T., Clifton P.M. Effect of beetroot juice on lowering blood pressure in free-living, disease-free adults: a randomized, placebo-controlled trial. Nutr J 2012, 11:106.
167. Kapil V., Haydar S.M., Pearl V., Lundberg J.O., Weitzberg E., Ahluwalia A. Physiological role for nitrate-reducing oral bacteria in blood pressure control. Free Radic Biol Med 2013, 55:93-100.
168. Liu M.W., Roubin G.S., King S.B. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation 1989, 79:1374-1387.
169. Kornowski R., Mintz G.S., Kent K.M., Pichard A.D., Satler L.F., Bucher T.A., et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. Circulation 1997, 95:1366-1369.
170. Rudic R.D., Shesely E.G., Maeda N., Smithies O., Segal S.S., Sessa W.C. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 1998, 101:731-736.
171. Fischer J.W., Hawkins S., Clowes A.W. Pharmacologic inhibition of nitric oxide synthases and cyclooxygenases enhances intimal hyperplasia in balloon-injured rat carotid arteries. J Vasc Surg 2004, 40:115-122.
172. Kenjale A.A., Ham K.L., Stabler T., Robbins J.L., Johnson J.L., Vanbruggen M., et al. Dietary nitrate supplementation enhances exercise performance in peripheral arterial disease. J Appl Physiol 2011, 110:1582-1591.
173. Hausenloy D.J., Yellon D.M. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest 2013, 123:92-100.
174. Turer A.T., Hill J.A. Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. Am J Cardiol 2010, 106:360-368.
175. Weerateerangkul P., Chattipakorn S., Chattipakorn N. Roles of the nitric oxide signaling pathway in cardiac ischemic preconditioning against myocardial ischemia-reperfusion injury. Med Sci Monit 2011, 17:RA44-RA52.
176. Jung K.H., Chu K., Ko S.Y., Lee S.T., Sinn D.I., Park D.K., et al. Early intravenous infusion of sodium nitrite protects brain against in vivo ischemia-reperfusion injury. Stroke 2006, 37:2744-2750.
177. Tripatara P., Patel N.S., Webb A., Rathod K., Lecomte F.M., Mazzon E., et al. Nitrite-derived nitric oxide protects the rat kidney against ischemia/reperfusion injury in vivo: role for xanthine oxidoreductase. J Am Soc Nephrol 2007, 18:570-580.
178. Nicholson C.K., Lambert J.P., Chow C.W., Lefer D.J., Calvert J.W. Chronic exercise downregulates myocardial myoglobin and attenuates nitrite reductase capacity during ischemia-reperfusion. J Mol Cell Cardiol 2013, 64:1-10.
179. Jones D.A., Andiapen M., Van-Eijl T.J., Webb A.J., Antoniou S., Schilling R.J., et al. The safety and efficacy of intracoronary nitrite infusion during acute myocardial infarction (NITRITE-AMI): study protocol of a randomised controlled trial. BMJ Open 2013, 3.
180. Siddiqi N., Bruce M., Neil C.J., Jagpal B., Maclennon G., Cotton S.C., et al. Protocol: does sodium nitrite administration reduce ischaemia-reperfusion injury in patients presenting with acute ST segment elevation myocardial infarction? Nitrites in acute myocardial infarction (NIAMI). J Transl Med 2013, 11.
181. Mo L., Wang Y., Geary L., Corey C., Alef M.J., Beer-Stolz D., et al. Nitrite activates AMP kinase to stimulate mitochondrial biogenesis independent of soluble guanylate cyclase. Free Radic Biol Med 2012, 53:1440-1450.
182. Chandel N.S., Maltepe E., Goldwasser E., Mathieu C.E., Simon M.C., Schumacker P.T. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci U S A 1998, 95:11715-11720.
183. Ow Y.P., Green D.R., Hao Z., Mak T.W. Cytochrome c: functions beyond respiration. Nat Rev Mol Cell Biol 2008, 9:532-542.
184. Solaini G., Harris D.A. Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion. Biochem J 2005, 390:377-394.
185. Stanley W.C. Cardiac energetics during ischaemia and the rationale for metabolic interventions. Coron Artery Dis 2001, 12(Suppl. 1):S3-S7.
186. Dennis S.C., Gevers W., Opie L.H. Protons in ischemia: where do they come from; where do they go to?. J Mol Cell Cardiol 1991, 23:1077-1086.
187. Vuorinen K., Ylitalo K., Peuhkurinen K., Raatikainen P., Ala-Rami A., Hassinen I.E. Mechanisms of ischemic preconditioning in rat myocardium. Roles of adenosine, cellular energy state, and mitochondrial F1F0-ATPase. Circulation 1995, 91:2810-2818.
188. Smith D.R., Stone D., Darley-Usmar V.M. Stimulation of mitochondrial oxygen consumption in isolated cardiomyocytes after hypoxia-reoxygenation. Free Radic Res 1996, 24:159-166.
189. Nohl H., Jordan W. The mitochondrial site of superoxide formation. Biochem Biophys Res Commun 1986, 138:533-539.
190. Vanden Hoek T.L., Shao Z., Li C., Schumacker P.T., Becker L.B. Mitochondrial electron transport can become a significant source of oxidative injury in cardiomyocytes. J Mol Cell Cardiol 1997, 29:2441-2450.
191. McCord J.M. Free radicals and myocardial ischemia: overview and outlook. Free Radic Biol Med 1988, 4:9-14.
192. Ambrosio G., Zweier J.L., Duilio C., Kuppusamy P., Santoro G., Elia P.P., et al. Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow. J Biol Chem 1993, 268:18532-18541.
193. Crow M.T., Mani K., Nam Y.J., Kitsis R.N. The mitochondrial death pathway and cardiac myocyte apoptosis. Circ Res 2004, 95:957-970.
194. Halestrap A.P. Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Trans 2006, 34:232-237.
195. Brown G.C., Cooper C.E. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett 1994, 356:295-298.
196. Cleeter M.W., Cooper J.M., Darley-Usmar V.M., Moncada S., Schapira A.H. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 1994, 345:50-54.
197. Stevens T.H., Brudvig G.W., Bocian D.F., Chan S.I. Structure of cytochrome a3-Cua3 couple in cytochrome c oxidase as revealed by nitric oxide binding studies. Proc Natl Acad Sci U S A 1979, 76:3320-3324.
198. Shiva S., Brookes P.S., Patel R.P., Anderson P.G., Darley-Usmar V.M. Nitric oxide partitioning into mitochondrial membranes and the control of respiration at cytochrome c oxidase. Proc Natl Acad Sci U S A 2001, 98:7212-7217.
199. Larsen F.J., Schiffer T.A., Borniquel S., Sahlin K., Ekblom B., Lundberg J.O., et al. Dietary inorganic nitrate improves mitochondrial efficiency in humans. Cell Metab 2011, 13:149-159.
200. Burwell L.S., Nadtochiy S.M., Tompkins A.J., Young S., Brookes P.S. Direct evidence for S-nitrosation of mitochondrial complex I. Biochem J 2006, 394:627-634.
201. Nadtochiy S.M., Burwell L.S., Brookes P.S. Cardioprotection and mitochondrial S-nitrosation: effects of S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) in cardiac ischemia-reperfusion injury. J Mol Cell Cardiol 2007, 42:812-825.
202. Vlasova I.I., Tyurin V.A., Kapralov A.A., Kurnikov I.V., Osipov A.N., Potapovich M.V., et al. Nitric oxide inhibits peroxidase activity of cytochrome c.cardiolipin complex and blocks cardiolipin oxidation. J Biol Chem 2006, 281:14554-14562.
203. Kagan V.E., Borisenko G.G., Tyurina Y.Y., Tyurin V.A., Jiang J., Potapovich A.I., et al. Oxidative lipidomics of apoptosis: redox catalytic interactions of cytochrome c with cardiolipin and phosphatidylserine. Free Radic Biol Med 2004, 37:1963-1985.
204. Kagan V.E., Tyurin V.A., Jiang J., Tyurina Y.Y., Ritov V.B., Amoscato A.A., et al. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol 2005, 1:223-232.
205. Shidoji Y., Hayashi K., Komura S., Ohishi N., Yagi K. Loss of molecular interaction between cytochrome c and cardiolipin due to lipid peroxidation. Biochem Biophys Res Commun 1999, 264:343-347.
206. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997, 275:1132-1136.
207. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997, 275:1129-1132.
208. Ong S.B., Subrayan S., Lim S.Y., Yellon D.M., Davidson S.M., Hausenloy D.J. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation 2010, 121:2012-2022.
209. Kim H., Scimia M.C., Wilkinson D., Trelles R.D., Wood M.R., Bowtell D., et al. Fine-tuning of Drp1/Fis1 availability by AKAP121/Siah2 regulates mitochondrial adaptation to hypoxia. Mol Cell 2011, 44:532-544.
210. Young L.H. AMP-activated protein kinase conducts the ischemic stress response orchestra. Circulation 2008, 117:832-840.
211. Cool B., Zinker B., Chiou W., Kifle L., Cao N., Perham M., et al. Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab 2006, 3:403-416.
212. Konishi M., Haraguchi G., Ohigashi H., Ishihara T., Saito K., Nakano Y., et al. Adiponectin protects against doxorubicin-induced cardiomyopathy by anti-apoptotic effects through AMPK up-regulation. Cardiovasc Res 2011, 89:309-319.
213. Zhu S.G., Kukreja R.C., Das A., Chen Q., Lesnefsky E.J., Xi L. Dietary nitratesupplementation protects against Doxorubicin-induced cardiomyopathy by improving mitochondrial function. J Am Coll Cardiol 2011, 57:2181-2189.
214. Xuan Y.T., Tang X.L., Qiu Y., Banerjee S., Takano H., Han H., et al. Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. Am J Physiol Heart Circ Physiol 2000, 279:H2360-H2371.
215. Smith B.C., Marletta M.A. Mechanisms of S-nitrosothiol formation and selectivity in nitric oxide signaling. Curr Opin Chem Biol 2012, 16:498-506.
216. Freeman B.A., Baker P.R., Schopfer F.J., Woodcock S.R., Napolitano A., d'Ischia M. Nitro-fatty acid formation and signaling. J Biol Chem 2008, 283:15515-15519.
217. Broniowska K.A., Hogg N. The chemical biology of S-nitrosothiols. Antioxid Redox Signal 2012, 17:969-980.
218. Madej E., Folkes L.K., Wardman P., Czapski G., Goldstein S. Thiyl radicals react with nitric oxide to form S-nitrosothiols with rate constants near the diffusion-controlled limit. Free Radic Biol Med 2008, 44:2013-2018.
219. Keszler A., Zhang Y.H., Hogg N. Reaction between nitric oxide, glutathione, and oxygen in the presence and absence of protein: how are S-nitrosothiols formed?. Free Radic Biol Med 2010, 48:55-64.
220. Broniowska K.A., Keszler A., Basu S., Kim-Shapiro D.B., Hogg N. Cytochrome c-mediated formation of S-nitrosothiol in cells. Biochem J 2012, 442:191-197.
221. Stamler J.S., Jaraki O., Osborne J., Simon D.I., Keaney J., Vita J., et al. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci U S A 1992, 89:7674-7677.
222. Lundberg J.O., Govoni M. Inorganic nitrate is a possible source for systemic generation of nitric oxide. Free Radic Biol Med 2004, 37:395-400.
223. O'Donnell V.B., Eiserich J.P., Chumley P.H., Jablonsky M.J., Krishna N.R., Kirk M., et al. Nitration of unsaturated fatty acids by nitric oxide-derived reactive nitrogen species peroxynitrite, nitrous acid, nitrogen dioxide, and nitronium ion. Chem Res Toxicol 1999, 12:83-92.
224. Baker P.R., Schopfer F.J., Sweeney S., Freeman B.A. Red cell membrane and plasma linoleic acid nitration products: synthesis, clinical identification, and quantitation. Proc Natl Acad Sci U S A 2004, 101:11577-11582.
225. Nadtochiy S.M., Baker P.R., Freeman B.A., Brookes P.S. Mitochondrial nitroalkene formation and mild uncoupling in ischaemic preconditioning: implications for cardioprotection. Cardiovasc Res 2009, 82:333-340.
226. Rudolph V., Rudolph T.K., Schopfer F.J., Bonacci G., Woodcock S.R., Cole M.P., et al. Endogenous generation and protective effects of nitro-fatty acids in a murine model of focal cardiac ischaemia and reperfusion. Cardiovasc Res 2010, 85:155-166.
227. Qipshidze-Kelm N., Piell K.M., Solinger J.C., Cole M.P. Co-treatment with conjugated linoleic acid and nitrite protects against myocardial infarction. Redox Biol 2013, 2:1-7.